Cargando...

Biological therapy for ulcerative colitis: An update

Of the diverse biological agents used for patients with ulcerative colitis, the anti-tumor necrosis factor-α agents infliximab and adalimumab have been used in large-scale clinical trials and are currently widely used in the treatment of inflammatory bowel disease patients. Recent studies have indic...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Seo, Geom Seog, Chae, Soo-Cheon
Formato: Artigo
Lenguaje:Inglês
Publicado: Baishideng Publishing Group Inc 2014
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4188881/
https://ncbi.nlm.nih.gov/pubmed/25309060
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i37.13234
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!